Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 225 of 341 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 01/03/22
End: 01/03/36
Due: 01/03/37
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 08/24/17
Due: 08/24/18
Phase: N/A
Priority: Normal
Start: 10/25/22
End: 09/12/23
Due: 09/12/24
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 02/01/12
End: 10/01/15
Due: 10/01/16
Phase: N/A
Priority: Normal
Start: 08/14/21
End: 07/15/22
Due: 07/15/23
Phase: N/A
Priority: Normal
Start: 04/08/19
End: 12/19/23
Due: 12/19/24
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 12/31/26
Due: 12/31/27
The Expression of TLR2 and TLR4 in the Lung of Chronic Obstructive Pulmonary Disease (COPD) Patients
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 08/02/22
End: 05/19/23
Due: 05/19/24
Phase: N/A
Priority: Normal
Start: 09/01/16
End: 12/07/17
Due: 12/07/18
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 06/15/17
End: 10/15/21
Due: 10/15/22
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 09/28/22
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 09/16/20
End: 03/19/21
Due: 03/19/22